Tanay Prashant Rangankar

Gemcitabine resistance in gallbladder cancer: mechanistic insights with emphasis on cancer stem cells

Gemcitabine remains the primary chemotherapeutic agent for multiple solid tumours; however, the development of resistance greatly limits its effectiveness. This resistance is multifactorial, including mechanisms affecting intracellular drug concentration, enhancement of DNA repai...